Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir

Virologic rebound more common among those who started therapy within 2 days of symptom onset

Related Keywords

Boston ,Massachusetts ,United States ,Gregorye Edelstein , ,Healthday News ,